Andrew is an Associate in the Sydney Chemistry team.
Andrew’s work spans prosecution, coordinating patent portfolios, oppositions, searching and freedom-to-operate opinions, drafting, and strategic advisory services. Andrew provides advice to both domestic and international clients, utilising Australian and New Zealand practice to help with the commercialisation of his clients’ products. His client base covers universities to global companies in a range of technological areas including: pharmaceuticals, polymers, veterinary sciences, green technology, inorganic materials and nanotechnology.
Andrew’s expertise is backed by technical knowledge gained from his hands on experience from working in laboratories. Over the years he has developed his synthetic and characterisation skills in organic and inorganic chemistry, with a particular focus in the field of polymers. He is able to implement this acquired knowledge in order to assist his clients with both the drafting and the prosecution of his clients’ patents. He is an author of research and review articles in high impact journals and has presented his work at international conferences.
Andrew earned a First Class Masters in Chemistry (Hons) from the University of Leicester, graduating top of his year. He went on to receive a PhD in Polymer Chemistry at the University of Nottingham, winning a national scholarship (SOCI Messel Scholar), and graduating in 2008. His thesis focused on the synthesis of various polymer architectures in supercritical carbon dioxide using controlled radical and enzymatic techniques.
As a Research Associate at the Centre of Advanced Macromolecular Design at the University of New South Wales, Andrew oversaw and coordinated a number of projects focussing primarily on the development of new polymer vehicles for delivering platinum based drugs. His work included collaborating with a highly regarded multinational company developing novel materials, based on commercially viable microspheres, for imaging and therapeutic applications in the treatment of liver cancer.
Andrew is a registered Australian and New Zealand Patent Attorney.